← All trials
NCT05247541
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2020
- Primary completion
- Jul 1, 2023
- Completion date
- Jul 1, 2023
- First posted
- Feb 21, 2022
- Last posted
- Jul 5, 2022
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Thomas Jefferson UniversityLead sponsor
- Lantheus Medical ImagingCollaborator
- Thomas Jefferson UniversityCollaborator
- Thomas Jefferson UniversityOverall official - principal investigator
- Thomas Jefferson UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.